CXCR2 BINDENDE POLYPEPTIDE

European patent · EP2638068 · Deleted

Register entry

Publication number
EP2638068
Application number
EP11785367
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 7, 2011
Published
Sep 18, 2013
Granted
Dec 26, 2018
Deleted
Nov 30, 2019
Reason
Annual fee unpaid
IPC classes
C07K 16/28 (2006.01)
Priority
US 411083 P 08.11.2010
PCT application
PCT/EP2011/069571 07.11.2011
PCT publication
WO2012/062713 18.05.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 17, 2020

    Deleted, fee unpaid

    Published in Swissreg on 17.06.2020

  2. May 29, 2019

    Owner

    Owner
    Novartis AG, Lichtstrasse 35, 4056 Basel → Ablynx N.V., Technologiepark 21, 9052 Zwijnaarde, Belgium

    Published in Swissreg on 29.05.2019

  3. Jan 7, 2019

    Granted

    Published in Swissreg on 07.01.2019

Parties

Holder

Ablynx N.V.

Technologiepark 21, 9052 Zwijnaarde, BE

Inventor

BROWN, Zarin

West Sussex Sussex RH12 5AB, GB

BRADLEY, Michelle

West Sussex Sussex RH12 5AB, GB

VAN HEEKE, Gino

West Sussex Sussex RH12 5AB, GB

STEFFENSEN, Soren

B-9052 Zwijnaarde, BE

CROMIE, Karen

B-9052 Zwijnaarde, BE

DOMBRECHT, Bruno

B-9052 Zwijnaarde, BE

CHARLTON, Steven John

West Sussex Sussex RH12 5AB, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.